[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 25, 1995

Physicians and Pharmaceutical Sales Representatives

Author Affiliations

ClinTrials Research Raleigh, NC

JAMA. 1995;274(16):1267-1268. doi:10.1001/jama.1995.03530160019020
Abstract

To the Editor.  —As a physician previously responsible for pharmaceutical sales training, I would like to respond to the article by Dr Ziegler and colleagues1 on the accuracy of sales information. My former company (Glaxo Wellcome Inc) strongly supports the position enunciated by Orlowski and Wateska.2 Patients have a right to expect that a service or product is recommended or prescribed because it is needed and because it is the most efficacious, the safest, and the most cost-effective, based on sound professional judgment. Glaxo has made a major effort to ensure that its representatives are trained to the highest professional standards to impart accurately and comprehensively the medical and technical knowledge that physicians require to use the company's products in their patients' best interests.With the development of new, more effective medicines with novel modes of action, company representatives have an important role in educating physicians in all

First Page Preview View Large
First page PDF preview
First page PDF preview
×